Bristol Myers Squibb

Mentioned in 6 analyzed podcast episodes across 6 shows

Mentioned On

Episode Mentions

“Preparing CFO and board for high token consumption costs while expecting positive ROI from AI deployment”

AI Spending Governance and FinOpsToken Consumption and Cost ControlAI-Driven Automation Failures

“Announced $15B partnership with Hengrui Pharma to advance 13 early-stage programs leveraging China's R&D capabilities”

FDA Leadership Transition and Regulatory StrategyPrecision Oncology and Targeted Breast Cancer TherapiesBiosimilar Competition and Market Erosion

“Previous employer where Dr. Sadeh held senior R&D leadership role before joining Bausch Health”

Career progression in large pharmaceutical organizationsCross-functional collaboration in drug developmentTherapeutic area diversification strategy

“Mentioned as company where Lorraine Marchand held previous leadership role in healthcare and life sciences”

Innovation Framework and StrategyOrganizational Culture and Psychological SafetyRisk Management and Strategic vs. Reckless Risk

The a16z Show · Feb 16, 2026

“Competitor mentioned in cell therapy development alongside other major pharma companies”

Corporate transformation and spin-offsCell and gene therapy platformsRNA therapeutics and siRNA technology

“Former employer of Sean Raymer, senior VP of drug discovery who joined Qualia's science team early on”

Complex Systems Science Applied to Human BiologyGut-Brain Axis and Neurotransmitter ProductionReductionist vs. Systems-Based Medical Models